Intrinsic value of Radnet - RDNT

Previous Close

$11.15

  Intrinsic Value

$5.61

stock screener

  Rating & Target

sell

-50%

  Value-price divergence*

-43%

Previous close

$11.15

 
Intrinsic value

$5.61

 
Up/down potential

-50%

 
Rating

sell

 
Value-price divergence*

-43%

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of RDNT stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2016), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 0.5

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  9.26
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
  5.00
Revenue, $m
  885
  929
  976
  1,024
  1,076
  1,130
  1,186
  1,245
  1,308
  1,373
  1,442
  1,514
  1,589
  1,669
  1,752
  1,840
  1,932
  2,028
  2,130
  2,236
  2,348
  2,466
  2,589
  2,718
  2,854
  2,997
  3,147
  3,304
  3,469
  3,643
  3,825
Variable operating expenses, $m
 
  883
  925
  971
  1,018
  1,068
  1,120
  1,174
  1,232
  1,292
  1,356
  1,398
  1,468
  1,542
  1,619
  1,700
  1,785
  1,874
  1,968
  2,066
  2,169
  2,278
  2,392
  2,511
  2,637
  2,769
  2,907
  3,053
  3,205
  3,365
  3,534
Fixed operating expenses, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  846
  883
  925
  971
  1,018
  1,068
  1,120
  1,174
  1,232
  1,292
  1,356
  1,398
  1,468
  1,542
  1,619
  1,700
  1,785
  1,874
  1,968
  2,066
  2,169
  2,278
  2,392
  2,511
  2,637
  2,769
  2,907
  3,053
  3,205
  3,365
  3,534
Operating income, $m
  38
  47
  50
  54
  58
  62
  66
  71
  76
  81
  86
  115
  121
  127
  133
  140
  147
  154
  162
  170
  179
  188
  197
  207
  217
  228
  240
  252
  264
  277
  291
EBITDA, $m
  105
  110
  115
  121
  127
  133
  140
  147
  154
  162
  170
  179
  188
  197
  207
  217
  228
  239
  251
  264
  277
  291
  305
  321
  337
  354
  371
  390
  409
  430
  451
Interest expense (income), $m
  37
  36
  36
  38
  41
  43
  46
  49
  51
  54
  58
  61
  65
  68
  72
  76
  80
  85
  90
  95
  100
  105
  111
  117
  123
  130
  137
  144
  152
  160
  168
Earnings before tax, $m
  12
  11
  14
  16
  17
  19
  21
  22
  24
  26
  28
  54
  56
  59
  61
  64
  67
  69
  72
  76
  79
  82
  86
  90
  94
  98
  103
  107
  112
  117
  123
Tax expense, $m
  4
  3
  4
  4
  5
  5
  6
  6
  7
  7
  8
  15
  15
  16
  17
  17
  18
  19
  20
  20
  21
  22
  23
  24
  25
  26
  28
  29
  30
  32
  33
Net income, $m
  7
  8
  10
  11
  13
  14
  15
  16
  18
  19
  21
  40
  41
  43
  45
  47
  49
  51
  53
  55
  58
  60
  63
  66
  69
  72
  75
  78
  82
  86
  90

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  21
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  849
  869
  913
  958
  1,006
  1,057
  1,109
  1,165
  1,223
  1,284
  1,349
  1,416
  1,487
  1,561
  1,639
  1,721
  1,807
  1,898
  1,992
  2,092
  2,197
  2,306
  2,422
  2,543
  2,670
  2,803
  2,944
  3,091
  3,245
  3,408
  3,578
Adjusted assets (=assets-cash), $m
  828
  869
  913
  958
  1,006
  1,057
  1,109
  1,165
  1,223
  1,284
  1,349
  1,416
  1,487
  1,561
  1,639
  1,721
  1,807
  1,898
  1,992
  2,092
  2,197
  2,306
  2,422
  2,543
  2,670
  2,803
  2,944
  3,091
  3,245
  3,408
  3,578
Revenue / Adjusted assets
  1.069
  1.069
  1.069
  1.069
  1.070
  1.069
  1.069
  1.069
  1.070
  1.069
  1.069
  1.069
  1.069
  1.069
  1.069
  1.069
  1.069
  1.068
  1.069
  1.069
  1.069
  1.069
  1.069
  1.069
  1.069
  1.069
  1.069
  1.069
  1.069
  1.069
  1.069
Average production assets, $m
  297
  311
  327
  343
  360
  378
  397
  417
  438
  460
  483
  507
  532
  559
  587
  616
  647
  680
  714
  749
  787
  826
  867
  911
  956
  1,004
  1,054
  1,107
  1,162
  1,220
  1,281
Working capital, $m
  63
  72
  76
  80
  84
  88
  93
  97
  102
  107
  112
  118
  124
  130
  137
  144
  151
  158
  166
  174
  183
  192
  202
  212
  223
  234
  245
  258
  271
  284
  298
Total debt, $m
  639
  620
  659
  701
  744
  789
  836
  886
  939
  994
  1,052
  1,112
  1,176
  1,243
  1,313
  1,387
  1,464
  1,546
  1,631
  1,721
  1,815
  1,914
  2,018
  2,127
  2,241
  2,361
  2,487
  2,620
  2,759
  2,905
  3,058
Total liabilities, $m
  801
  782
  821
  863
  906
  951
  998
  1,048
  1,101
  1,156
  1,214
  1,274
  1,338
  1,405
  1,475
  1,549
  1,626
  1,708
  1,793
  1,883
  1,977
  2,076
  2,180
  2,289
  2,403
  2,523
  2,649
  2,782
  2,921
  3,067
  3,220
Total equity, $m
  48
  87
  91
  96
  101
  106
  111
  116
  122
  128
  135
  142
  149
  156
  164
  172
  181
  190
  199
  209
  220
  231
  242
  254
  267
  280
  294
  309
  325
  341
  358
Total liabilities and equity, $m
  849
  869
  912
  959
  1,007
  1,057
  1,109
  1,164
  1,223
  1,284
  1,349
  1,416
  1,487
  1,561
  1,639
  1,721
  1,807
  1,898
  1,992
  2,092
  2,197
  2,307
  2,422
  2,543
  2,670
  2,803
  2,943
  3,091
  3,246
  3,408
  3,578
Debt-to-equity ratio
  13.313
  7.140
  7.230
  7.310
  7.390
  7.470
  7.540
  7.610
  7.680
  7.740
  7.800
  7.860
  7.910
  7.960
  8.010
  8.060
  8.100
  8.150
  8.190
  8.230
  8.260
  8.300
  8.330
  8.360
  8.390
  8.420
  8.450
  8.480
  8.500
  8.520
  8.550
Adjusted equity ratio
  0.033
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  7
  8
  10
  11
  13
  14
  15
  16
  18
  19
  21
  40
  41
  43
  45
  47
  49
  51
  53
  55
  58
  60
  63
  66
  69
  72
  75
  78
  82
  86
  90
Depreciation, amort., depletion, $m
  67
  63
  65
  67
  69
  71
  74
  76
  79
  81
  84
  63
  67
  70
  73
  77
  81
  85
  89
  94
  98
  103
  108
  114
  120
  125
  132
  138
  145
  153
  160
Funds from operations, $m
  62
  71
  75
  78
  82
  85
  89
  92
  96
  101
  105
  103
  108
  113
  118
  124
  130
  136
  142
  149
  156
  163
  171
  179
  188
  197
  207
  217
  227
  238
  250
Change in working capital, $m
  -30
  3
  4
  4
  4
  4
  4
  5
  5
  5
  5
  6
  6
  6
  7
  7
  7
  8
  8
  8
  9
  9
  10
  10
  11
  11
  12
  12
  13
  14
  14
Cash from operations, $m
  92
  67
  72
  75
  78
  81
  84
  88
  92
  95
  100
  97
  102
  107
  112
  117
  122
  128
  134
  141
  147
  154
  162
  169
  177
  186
  195
  204
  214
  225
  236
Maintenance CAPEX, $m
  0
  -37
  -39
  -41
  -43
  -45
  -47
  -50
  -52
  -55
  -57
  -60
  -63
  -67
  -70
  -73
  -77
  -81
  -85
  -89
  -94
  -98
  -103
  -108
  -114
  -120
  -125
  -132
  -138
  -145
  -153
New CAPEX, $m
  -66
  -15
  -16
  -16
  -17
  -18
  -19
  -20
  -21
  -22
  -23
  -24
  -25
  -27
  -28
  -29
  -31
  -32
  -34
  -36
  -37
  -39
  -41
  -43
  -46
  -48
  -50
  -53
  -55
  -58
  -61
Cash from investing activities, $m
  -65
  -52
  -55
  -57
  -60
  -63
  -66
  -70
  -73
  -77
  -80
  -84
  -88
  -94
  -98
  -102
  -108
  -113
  -119
  -125
  -131
  -137
  -144
  -151
  -160
  -168
  -175
  -185
  -193
  -203
  -214
Free cash flow, $m
  27
  16
  17
  17
  18
  18
  18
  18
  18
  19
  19
  13
  13
  13
  14
  14
  14
  15
  15
  16
  16
  17
  17
  18
  18
  19
  19
  20
  21
  21
  22
Issuance/(repayment) of debt, $m
  -4
  2
  39
  41
  43
  45
  48
  50
  52
  55
  58
  61
  64
  67
  70
  74
  77
  81
  85
  90
  94
  99
  104
  109
  114
  120
  126
  132
  139
  146
  153
Issuance/(repurchase) of shares, $m
  0
  31
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  -6
  33
  39
  41
  43
  45
  48
  50
  52
  55
  58
  61
  64
  67
  70
  74
  77
  81
  85
  90
  94
  99
  104
  109
  114
  120
  126
  132
  139
  146
  153
Total cash flow (excl. dividends), $m
  20
  49
  56
  58
  61
  63
  66
  68
  71
  74
  77
  74
  77
  80
  84
  88
  92
  96
  101
  105
  110
  115
  121
  127
  133
  139
  145
  152
  160
  167
  175
Retained Cash Flow (-), $m
  -15
  -39
  -4
  -5
  -5
  -5
  -5
  -6
  -6
  -6
  -6
  -7
  -7
  -7
  -8
  -8
  -9
  -9
  -9
  -10
  -10
  -11
  -12
  -12
  -13
  -13
  -14
  -15
  -15
  -16
  -17
Prev. year cash balance distribution, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  10
  52
  54
  56
  58
  60
  63
  65
  68
  70
  67
  70
  73
  76
  80
  83
  87
  91
  95
  100
  104
  109
  114
  120
  125
  131
  138
  144
  151
  158
Discount rate, %
 
  12.10
  12.71
  13.34
  14.01
  14.71
  15.44
  16.22
  17.03
  17.88
  18.77
  19.71
  20.70
  21.73
  22.82
  23.96
  25.16
  26.41
  27.73
  29.12
  30.58
  32.10
  33.71
  35.40
  37.17
  39.02
  40.97
  43.02
  45.17
  47.43
  49.81
PV of cash for distribution, $m
 
  9
  41
  37
  33
  29
  25
  22
  19
  15
  13
  9
  7
  6
  4
  3
  2
  2
  1
  1
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Current shareholders' claim on cash, %
  100
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9
  93.9

RadNet, Inc. is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island. Its centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. As of December 31, 2016, the Company had in operation 257 MRI systems, 157 CT systems, 47 PET or combination PET/CT systems, 48 nuclear medicine systems, 479 X-ray systems, 279 mammography systems, 551 ultrasound systems and 104 fluoroscopy systems.

FINANCIAL RATIOS  of  Radnet (RDNT)

Valuation Ratios
P/E Ratio 74.2
Price to Sales 0.6
Price to Book 10.8
Price to Tangible Book
Price to Cash Flow 5.6
Price to Free Cash Flow 20
Growth Rates
Sales Growth Rate 9.3%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -50.7%
Cap. Spend. - 3 Yr. Gr. Rate 3.3%
Financial Strength
Quick Ratio 1
Current Ratio 0
LT Debt to Equity 1275%
Total Debt to Equity 1331.3%
Interest Coverage 1
Management Effectiveness
Return On Assets 3.8%
Ret/ On Assets - 3 Yr. Avg. 3.5%
Return On Total Capital 1%
Ret/ On T. Cap. - 3 Yr. Avg. 0.8%
Return On Equity 17.3%
Return On Equity - 3 Yr. Avg. 33.1%
Asset Turnover 1.1
Profitability Ratios
Gross Margin 20.7%
Gross Margin - 3 Yr. Avg. 22.3%
EBITDA Margin 13.1%
EBITDA Margin - 3 Yr. Avg. 13.9%
Operating Margin 4.4%
Oper. Margin - 3 Yr. Avg. 4.8%
Pre-Tax Margin 1.4%
Pre-Tax Margin - 3 Yr. Avg. 1.3%
Net Profit Margin 0.8%
Net Profit Margin - 3 Yr. Avg. 0.6%
Effective Tax Rate 33.3%
Eff/ Tax Rate - 3 Yr. Avg. 41.1%
Payout Ratio 0%

RDNT stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the RDNT stock intrinsic value calculation we used $885 million for the last fiscal year's total revenue generated by Radnet. The default revenue input number comes from 2016 income statement of Radnet. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our RDNT stock valuation model: a) initial revenue growth rate of 5% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 12.1%, whose default value for RDNT is calculated based on our internal credit rating of Radnet, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Radnet.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of RDNT stock the variable cost ratio is equal to 95.1%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for RDNT stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.8% for Radnet.

Corporate tax rate of 27% is the nominal tax rate for Radnet. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the RDNT stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for RDNT are equal to 33.5%.

Life of production assets of 8 years is the average useful life of capital assets used in Radnet operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for RDNT is equal to 7.8%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $48 million for Radnet - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 46.785 million for Radnet is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Radnet at the current share price and the inputted number of shares is $0.5 billion.

RELATED COMPANIES Price Int.Val. Rating
DRAD Digirad 2.35 1.11  str.sell
DGX Quest Diagnost 92.05 116.55  hold
CBMX CombiMatrix 7.90 93.85  str.buy
ENZ Enzo Biochem 9.82 1.29  str.sell
PMD Psychemedics 16.89 20.18  hold

COMPANY NEWS

▶ ETFs with exposure to RadNet, Inc. : October 13, 2017   [Oct-13-17 11:10AM  Capital Cube]
▶ ETFs with exposure to RadNet, Inc. : October 2, 2017   [Oct-02-17 11:03AM  Capital Cube]
▶ RadNet posts 2Q profit   [Aug-08-17 04:32PM  Associated Press]
▶ ETFs with exposure to RadNet, Inc. : July 5, 2017   [Jul-05-17 01:07PM  Capital Cube]
▶ RadNet, Inc. Acquires Equity Stake in Medic Vision   [Jun-20-17 09:15AM  PR Newswire]
▶ ETFs with exposure to RadNet, Inc. : June 8, 2017   [Jun-08-17 01:54PM  Capital Cube]
▶ RadNet reports 1Q loss   [06:12AM  Associated Press]
▶ Shin Imaging Center Implements eRAD Platform   [Apr-24-17 08:10AM  GlobeNewswire]
▶ Adams Diagnostic Innovates with eRAD Technology   [Apr-21-17 09:15AM  GlobeNewswire]
▶ Advanced Diagnostic Imaging Center Deploys eRAD Platform   [Apr-20-17 09:00AM  GlobeNewswire]
▶ ETFs with exposure to RadNet, Inc. : April 5, 2017   [Apr-05-17 05:20PM  Capital Cube]
▶ RadNet posts 4Q profit   [06:24AM  Associated Press]
▶ Is Akebia Therapeutics Inc (AKBA) A Good Stock To Buy?   [Dec-17-16 04:27PM  at Insider Monkey]
▶ Is RadNet Inc. (RDNT) Going to Burn These Hedge Funds?   [Dec-13-16 11:59PM  at Insider Monkey]
▶ RadNet Presents at 2016 WEDI-Con   [Nov-03-16 10:30AM  GlobeNewswire]
▶ RadNet Wins HHS A Bill You Can Understand Design Challenge   [Sep-30-16 08:00AM  GlobeNewswire]
▶ 5 Healthcare Stocks Near the Top of Cheyne Capitals Portfolio   [Aug-10-16 08:48AM  at Insider Monkey]
Financial statements of RDNT
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

VALUATION THEORY       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2017. All rigths reserved.